Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | P16070 | CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44) | Blood group antigen proteinsCancer-related genesCD markers | 1 | Ovarian cancerRetinopathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 61 | 0.88 | ||
| GBB1 | P62873 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1) | Cancer-related genesDisease related genesHuman disease related genes | Intellectual disability | Clinical-translation mediationFusion and delivery mediationImmune mediation | 42 | 0.88 | |||
| CD14 | P08571 | Monocyte differentiation antigen CD14 (My23 antigen) (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] | Cancer-related genesCD markersHuman disease related genes | COVID-19Sepsis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 37 | 0.88 | |||
| EF2 | P13639 | Elongation factor 2 (EF-2) (EC 3.6.5.-) | Cancer-related genesDisease related genesEssential proteins | Spinocerebellar ataxia | Clinical-translation mediationImmune mediationMetabolism mediation | 35 | 0.88 | |||
| AGRIN | O00468 | Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] | Disease related genesHuman disease related genesPlasma proteins | Congenital myasthenic syndrome | Clinical-translation mediationImmune mediationMetabolism mediation | 32 | 0.88 | |||
| DPEP1 | P16444 | Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) | EnzymesFDA approved drug targetsMetabolic proteins | Bacterial infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 32 | 0.88 | |||
| CYTB | P04080 | Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B) | Cancer-related genesDisease related genesHuman disease related genes | Ectodermal dysplasia | Immune mediation | 31 | 0.88 | |||
| DAF | P08174 | Complement decay-accelerating factor (CD antigen CD55) | Blood group antigen proteinsCD markersDisease related genes | Bladder cancerBrain cancerColorectal cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 31 | 0.88 | |||
| CD47 | Q08722 | Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 5 | Acute myeloid leukaemiaB-cell lymphomaColorectal cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 29 | 0.88 | ||
| EPHA4 | P54764 | Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK) | Cancer-related genesEnzymesPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 24 | 0.88 |